Indianapolis, IN, United States of America

Stephanie Ruth Coffin

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Eli Lilly and Company. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephanie Ruth Coffin. Retrieved from https://idiyas.com/inventor/stephanie-ruth-coffin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stephanie Ruth Coffin

Introduction

Stephanie Ruth Coffin is an accomplished inventor based in Indianapolis, IN. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative treatments. Her work is recognized for its potential impact on healthcare and patient outcomes.

Latest Patents

Coffin holds a patent for a groundbreaking invention titled "Process for Preparing a GIP/GLP1 Dual Agonist." This patent represents her commitment to advancing medical science and improving therapeutic options for patients.

Career Highlights

Coffin is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. Her role at Eli Lilly allows her to collaborate with other experts in the field and contribute to the development of new medications that can enhance the quality of life for many individuals.

Conclusion

Stephanie Ruth Coffin exemplifies the spirit of innovation in the pharmaceutical industry. Her patent and work at Eli Lilly and Company highlight her dedication to improving healthcare through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…